Cytological spectrum of Thyroid Lesions Using Recent Bethesda System of Reporting and its Correlation with Histomorphology: A Retrospective Study of 208 Cases in a Tertiary Care Rural Centre
DOI:
https://doi.org/10.52783/jns.v14.3282Keywords:
Thyroid nodule, Fine needle Aspiration Cytology, Bethesda system, Risk of MalignancyAbstract
Introduction : Enlargement of the thyroid gland or goiter is one of the important manifestation of thyroid lesions. It can be 
unilateral, bilateral or solitary nodule. It is very important to differentiate these lesions by clinical examination, thyroid 
function test and fine needle aspiration cytology (FNAC). It has been proved that fine needle aspiration cytology of the 
thyroid lesion is not only widely accepted but also simple, safe, cost effective, less painful and accurate method 
Material and Methods : The present study was a retrospective study conducted at Uttar Pradesh University of Medical 
Sciences (UPUMS), Saifai, Etawah. UPUMS is a 1500 bedded tertiary care rural hospital in north India. We collected data 
of 208 cases from January 2022 to June 2024 of all patients who underwent fine needle aspiration of thyroid lesions. The 
skin overlying the swelling was cleaned with alcohol and FNAC was done using 22-23 gauge disposable needle attached to 
a 10 ml plastic disposable syringe. Smears were prepared, air dried and fixe 
Results : The total 208 cases were archived from the Hospital Information System from January 2022 to June 2024. Out of 
which 24 were (11.5%) male and 184 (88.5%) were females with male to female ratio of (1:7.6 ). We reported11 cases as 
malignant in TBSRTC Category VI on FNAC, of which only eight cases were received for histopathological examination. 
We have found 100% correlation with cytological diagnosis in all the eight cases. Of these seven cases were reported as 
papillary carcinoma of thyroid and single case was reported as medullary carcinoma which was also confirmed by 
immunohistochmistry showed diffuse and strong positivity of calcitonin [Fig 13], focal weak positivity of TTF1 and negative 
thyroglobulin, giving the rate of malignancy 100% for this category 
Discussion : The malignancy rate of malignant category was observed to be 100% which is compatible with the studies 
conducted by Agarwal P et al [5], Arun et al [16], Williams et al [18], Mufti et al [19] and Theoharis et al [21]. While few 
of the studies conducted by Yang et al [22], Jo et al [20], Mondal et al [17] Nayar et al [23] and Yassa et al [6] had malignant 
rate between 97-99% in category VI. 
Conclusion : FNAC is very useful first line investigation of thyroid nodule and has been proved that it is not only widely 
accepted but also simple, safe, cost effective, minimally invasive, less painful and accurate method. Although it is used with 
success in diagnosing clear cut malignant cases but difficulty arises in follicular as well as Grey zone lesions. Hence by using 
TBSRTC system for reporting thyroid lesions, not only standardize the reporting but also help the clinician in planning 
further management of the patients.
Downloads
Metrics
References
Ellenson LH, Pirog EC. The female genital tract In: Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and
Cotran Pathological basis of disease 8th Edition Philadelphia: Saunders Elsevier 2012; 1005-1064.
Jeelani. T, Rafiq D, Nazir W, Shafi Y, Bashir N, Charak A, et al. Histopathological and cytological correlation
of thyroid nodules with emphasis on Bethesda System for reporting thyroid cytology, A 7 year study. Int J
Contemp Med Res 2018; 5: 28-31
P N Kadam1 , Nafela A Siddiqui2 , Deepak S Sadhu. Evaluation of Bethesda System for Reporting Thyroid
Cytology with Histopathological Correlation. JMSCR 2020 08:01, 573-580.
Syed M, Akhtar N, Hameed M, Mushtaq S, Loya A, Hassan U, Hussain M. Cytological and histopathological
correlation of thyroid lesions. J Pak Med Assoc. 2022 Feb;72(2):300-304. doi: 10.47391/JPMA.2224. PMID:
Agarwal P, Dahiya S, Shams A. Cytomorphological spectrum of thyroid lesions using Bethesda system of
reporting with Histopathological correlation: A study of 87 cases. Indian J Pathol Oncol 2019;6(3):454-9.
Yassa L, Cibas ES, Benson CB, Frates MC. Long Term Assessment of a multidisciplinary Approach to Thyroid
Nodule Diagnostic Evaluation. Cancer Cytopathol 2007:508- 16. 4.
Lobo C, Mc Queen A, Beale T. The UK Royal College of Pathologists thyroid fine-needle aspiration diagnostic
classification is a robust tool for clinical management of abnormal thyroid nodules. Acta Cytol 2011; 55: 499
Sinna EA, Ezzat N. Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions. J Egypt Natl Canc
Inst 2012; 24: 63-70.
Baloch ZW, LiVolsi VA, Asa SL. Diagnostic Terminology and Morphologic Criteria for Cytologic Diagnosis
of Thyroid Lesions: A Synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the
Science Conference. Diagn Cytopathol 2008;36:425-37.
Baloch Z, LiVolsi VA. The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look-backs to
look-ahead. Diagn Cytopathol. 2020 Oct;48(10):862-866. doi: 10.1002/dc.24385. Epub 2020 Jan 30. PMID:
Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for
Reporting Thyroid Cytopathology. Thyroid. 2023 Sep;33(9):1039-1044. doi: 10.1089/thy.2023.0141. Epub
Jul 8. PMID: 37427847.
Handa U, Garg S, Mohan H Nagarkar N. Role of Fine Needle Aspiration Cytology in Diagnosis and
Management of Thyroid Lesions: A study on 434 patients. J Cytol 2008;25:13-17. 3] Reddy P, Prakash A, Giriyan SS. Evaluation of Bethesda system for Reporting Thyroid Cytology with
Histopathological Correlation. Int J Res Med Sci 2018;6:247-52.
Mandreker, SR., Nadkarni, NS, Pinto, RG and Menezes, S. Role of fine needle aspiration cytology as the initial
modality in the investigation of thyroid lesions. Acta Cytologica. 1995; 39: 898-904.
Al-Rikabi, AC, Al-Omran, M., Cheema, M, El-Khwsky F. and Al-Nuaim A. Pattern of thyroid lesions and role
of fine needle aspiration cytology (FNA) in the management of thyroid enlargement: a retrospective study from
a teaching hospital in Riyadh. APMIS. 1998; 106:1069–1074.
Arul P, Akshatha C, Masilamani S. A Study of Malignancy Rates in Different Diagnostic Categories of the
Bethesda System for Reporting Thyroid Cytopathology: Institutional Experience. Biomed J 2015:517-22.
Mondal SK, Sinha S, Basak B, Roy DN. The Bethesda System for Reporting Thyroid Fine Needle Aspirates:
A Cytologic Study with Histologic Follow up. J Cytol 2013;30:94-9.
Williams BA, Bullock MJ, Trites JR. Rates of Thyroid Malignancy by FNA Diagnostic Category. J Otolaryngol
Head Neck Surg 2013:61.
Mufti ST, Molah R. The Bethesda System for Reporting Thyroid Cytopathology: A Five Year Retrospective
Review of One Center Experience. Int J Health Sci 2012;6:159-73.
Jo VY, Stelow EB, Dustin SM, Hanley KZ. Malignancy Risk for Fine Needle Aspiration of Thyroid Lesions
According to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 2010;134:450-6.
Theoharis CG, Schofield KM, Hmamers L, Udelsman R. The Bethesda Thyroid Fine Needle Aspiration
Classification Sysytem: Year 1 at an Academic Institution. Thyroid 2009:19:1215-23.
Yang J, Schanadig V, Logrono R, Wasserman PG. Fine Needle Aspiration of Thyroid Nodules: A Study of
Patients with Histologic and Clinical Correlations. Cancer 2007;111:306-15.
Nayar R, Ivanovic M. The Indeterminate Thyroid Fine Needle Aspiration: Experience from an Academic
Centre Using Terminology Similar to that Proposed in the 2007 National Cancer Institute Thyroid Fine Needle
Aspiration State of the Science Conference. Cancer Cytopathol 2009:195-202.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
 - Adapt — remix, transform, and build upon the material for any purpose, even commercially.
 
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
 - No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
 
						
			
		
			
			
				
